Andere Kunden interessierten sich auch für
![Who Owns This Sentence?]( "Who Owns This Sentence?")
Who Owns This Sentence?26,99 €![Decisions of the Commissioner of Patents and of the United States Courts in Patent and Trade-Mark and Copyright Cases, Volumes 462-473]( "Decisions of the Commissioner of Patents and of the United States Courts in Patent and Trade-Mark and Copyright Cases, Volumes 462-473")
Decisions of the Commissioner of Patents and of the United States Courts in Patent and Trade-Mark and Copyright Cases, Volumes 462-47343,99 €![Arguments Before the Committee On Patents of the House of Representatives, Conjointly With the Senate Committee On Patents, On H.R. 19853, to Amend an]( "Arguments Before the Committee On Patents of the House of Representatives, Conjointly With the Senate Committee On Patents, On H.R. 19853, to Amend an")
Arguments Before the Committee On Patents of the House of Representatives, Conjointly With the Senate Committee On Patents, On H.R. 19853, to Amend an41,99 €![Software and Patents in Europe]( "Software and Patents in Europe")
Software and Patents in Europe151,99 €![Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?]( "Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?")
Patent Strategy in Pharmaceutical Industry: Are additional patents valuable?24,00 €![Cultural Property Disputes: The Role of Arbitration in Resolving Non Contractual Disputes]( "Cultural Property Disputes: The Role of Arbitration in Resolving Non Contractual Disputes")
Cultural Property Disputes: The Role of Arbitration in Resolving Non Contractual Disputes215,99 €![Q&A Intellectual Property Law]( "Q&A Intellectual Property Law")
Q&A Intellectual Property Law197,99 €
The pharmaceutical industry and patent legislation are inextricably linked. Pharmaceutical companies could not exist without some guarantee that they can recoup the cost of developing a new product. European patent law offers this opportunity, as it allows companies to exclude competition for a specific product for a fixed time scale. In Pharmaceutical Patents in Europe the current legal patent situation is examined by a detailed analysis of case law from the European Patent Office (EPO), the international body created with the signing of the European Patent Convention (EPC). Aspects of European patent law not primarily regulated in the EPC, for example Supplementary Protection Certificates and infringement matters, are examined in the setting provided by EC law and domestic laws of European states. This book is written for the reader who understands the main characteristics of patent law and is looking for a practitioner's text on the European pharmaceutical patent law scene. Moreover, the author's remarks can help all readers to look at the field with fresh eyes.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.